- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced NSCLC
Total 6599 results
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.CompletedLocally Advanced or Metastatic NSCLCChina
-
Xuanzhu Biopharmaceutical Co., Ltd.Not yet recruiting
-
Shanghai Huaota Biopharmaceutical Co., Ltd.RecruitingNSCLC | Advanced Solid TumorUnited States, China
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.CompletedLocally Advanced or Metastatic NSCLCChina
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingNSCLC | Advanced Solid Tumor | CRCUnited States
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR(+) NSCLC PatientsChina
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR Mutated NSCLC.Taiwan
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Hatim HusainActive, not recruitingAdvanced NSCLCUnited States
-
Regeneron PharmaceuticalsRecruiting
-
AmgenNo longer availableNon Small-cell Lung Cancer | Locally Advanced Unresectable NSCLC | Locally Advanced Metastatic NSCLCUnited States, Taiwan, Israel, Saudi Arabia, Brazil, Argentina
-
Arbeitsgemeinschaft medikamentoese TumortherapieRecruitingLung Cancer | NSCLC Stage IV | NSCLC, Stage III | SCLC, Extensive Stage | SCLC, Limited StageAustria
-
German Cancer Research CenterUniversity Hospital Heidelberg; National Center for Tumor Diseases, HeidelbergCompleted
-
Seoul National University HospitalSeoul National University Bundang Hospital; SMG-SNU Boramae Medical CenterActive, not recruitingLocally Advanced or Metastatic NSCLCKorea, Republic of
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of, China, Japan
-
Yongchang ZhangRecruitingHER2 Insertion Mutation Positive Advanced NSCLCChina
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.RecruitingLocally Advanced or Metastatic NSCLCChina
-
University of California, Los AngelesUniversity of California, San Francisco; University of California, IrvineActive, not recruitingAdvanced Cancer | Advance Care Planning | Advance DirectivesUnited States
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR T790M+ NSCLCCanada, Korea, Republic of, Taiwan
-
Mythic TherapeuticsRecruitingNon-Small Cell Lung Cancer | NSCLC | Advanced Non-Small Cell Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIB | Advanced Non-Small Cell Squamous Lung Cancer | Advanced Non-Small Cell Non-Squamous Lung CancerUnited States, Australia, Korea, Republic of, United Kingdom
-
Simcere Pharmaceutical Co., LtdUnknownAdvanced NSCLC | Recurrent NSCLCChina
-
Jun Zhang, MD, PhDGenentech, Inc.; ExelixisNot yet recruitingLung Cancer | NSCLC Stage IV | Advanced NSCLC | Metastatic NSCLC - Non-Small Cell Lung CancerUnited States
-
AstraZenecaCompletedCaucasian Patients With EGFR Mutation Positive Advanced NSCLCBulgaria, Italy, Poland, Spain, Turkey, United Kingdom, Romania, Norway, Hungary, Portugal, Greece, Switzerland, France
-
CJ Bioscience, Inc.RecruitingMelanoma | NSCLC | Metastatic Cancer | Advanced Solid Tumor | Advanced Cancer | HNSCCKorea, Republic of
-
Daping Hospital and the Research Institute of Surgery...Not yet recruitingNSCLC | Advanced Cancer | Stage IV NSCLC | BRAF V600E Mutation | Stage IIIB NSCLC
-
MediLink Therapeutics (Suzhou) Co., Ltd.RecruitingBreast Cancer | NSCLC | HNSCC | Locally Advanced or Metastatic Solid TumorsChina
-
Jiangsu Simcere Pharmaceutical Co., Ltd.UnknownAdvanced or Metastatic Gastric Cancer | Advanced or Metastatic CRC | Advanced or Metastatic Liver Cancer | Advanced or Metastatic Non Squamous NSCLCChina
-
Henan Cancer HospitalUnknownAdvanced NSCLC With EGFR MutationChina
-
Daping Hospital and the Research Institute of Surgery...CompletedNSCLC | Advanced Cancer | EGFR Gene Amplification | Stage IV NSCLC | Stage IIIB NSCLCChina
-
Sunshine Lake Pharma Co., Ltd.Not yet recruiting
-
Qilu Hospital of Shandong UniversityUnknown
-
Peking University Cancer Hospital & InstituteEnrolling by invitationLocally Advanced NSCLCChina
-
AstraZenecaRecruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced or Metastatic NSCLCChina
-
Sheba Medical CenterRambam Health Care Campus; AstraZeneca; Tel-Aviv Sourasky Medical CenterRecruitingMetastatic or Locally Advanced NSCLCIsrael
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Not yet recruitingAdvanced or Metastatic NSCLCChina
-
Mt. Sinai Medical Center, MiamiAmgenCompletedUnresectable Locally Advanced NSCLCUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic NSCLC | Recurrent NSCLC | Advanced Non-Small Cell Squamous Lung CancerChina
-
Palobiofarma SLOhio State UniversityActive, not recruiting
-
Seoul National University HospitalAstraZeneca; Korean Cancer Study GroupCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of
-
Fujian Cancer HospitalEnrolling by invitationEGFR/ ALK-negative Advanced NSCLCChina
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCLCChina
-
AmgenActive, not recruitingKRAS p, G12c Mutated /Advanced Metastatic NSCLCFinland, United States, Canada, Belgium, Spain, Korea, Republic of, Netherlands, United Kingdom, Australia, Denmark, Hungary, Sweden, Taiwan, Greece, Russian Federation, Switzerland, France, Italy, Japan, Poland, Brazil, Germany, Po...
-
The First Affiliated Hospital, Guangzhou University...Not yet recruiting
-
Mirati Therapeutics Inc.Aadi Bioscience, Inc.RecruitingNSCLC | Metastatic Cancer | Advanced Cancer | Solid Tumor, Adult | Malignant Neoplastic DiseaseUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingUntreated Advanced NSCLC Patients | FISH Identified ALK Fusion Positive or NegativeChina
-
PfizerActive, not recruitingOvarian Cancer | NSCLC | Solid Tumors | Urothelial Cancer | Advanced MalignanciesHungary, Spain, United States, Canada, Taiwan, Japan, Serbia, Italy, New Zealand, Australia, Mexico, Russian Federation, United Kingdom, France, Korea, Republic of, Belgium, Poland, Denmark, Israel
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingNSCLC | AML | SCLC | Ovarian Carcinoma | Malignant Tumor | ESCC | CRPC | MFChina
-
Maastricht Radiation OncologyAcademisch Ziekenhuis MaastrichtTerminatedNSCLC | Lung Cancer | SCLCNetherlands
-
Institut Paoli-CalmettesSociété Francophone d'Onco-GériatrieUnknownAdvanced or Metastatic NSCLC | Advanced or Metastatic MelanomaFrance